InVitae (NVTA) Tops Q4 EPS by 2c, Revenues Miss

Go back to InVitae (NVTA) Tops Q4 EPS by 2c, Revenues Miss

Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019

February 19, 2020 4:05 PM EST

SAN FRANCISCO, Feb. 19, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the fourth quarter and full year ended December 31, 2019.

... More